Regulatory T cells in Crohn's disease following anti‐TNF‐α therapy
Background and Aim Anti‐tumor necrosis factor alpha (TNF‐α) therapy is an effective therapy for Crohn's disease (CD). We investigated FoxP3+ and CD127− regulatory T cells (Tregs) before and after administration of anti‐TNF‐α therapy in CD. Methods Eight patients with active CD who had received...
Main Authors: | Toshimi Chiba, Mikiya Endo, Shoko Miura, Yuko Hayashi, Yoshiko Asakura, Kotaro Oyama, Takayuki Matsumoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-06-01
|
Series: | JGH Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/jgh3.12259 |
Similar Items
-
The Role of T Regulatory Lymphocytes in Lymphoma
by: Ahmad Nasser, et al.
Published: (2014-03-01) -
Distribution of FoxP3+regulatoryT-cells in rat’spancreatic lymph nodes under streptozotocin-induced diabetes and metformin administration
by: D. A. Putilin, et al.
Published: (2015-04-01) -
TNFα-Signaling Modulates the Kinase Activity of Human Effector Treg and Regulates IL-17A Expression
by: Paulo C. M. Urbano, et al.
Published: (2020-01-01) -
ROLE OF THE REGULATORY T CELLS IN PROGRESSION OF PROSTATE CANCER
by: S. V. Popov, et al.
Published: (2019-10-01) -
Impact of in vitro HIV infection on human thymic regulatory T cell differentiation
by: Sharada Swaminathan, et al.
Published: (2023-07-01)